1901 - 1925 of 8808 Results
Title
Year
- Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease2021OPENTitle: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00250-2Best OA location URL: https://www.nature.com/articles/s41531-021-00250-2.pdfCitation Count: 15
-
OPENTitle: Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptanceJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 51Issue #: 5Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-023-06566-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-023-06566-w.pdfCitation Count: 6
-
OPENTitle: Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 42Issue #:Start Page: 103592End Page: 103592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2024.103592Best OA location URL: https://doi.org/10.1016/j.nicl.2024.103592Citation Count: 2
-
OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 15
-
OPENTitle: Oromandibular Dystonia: A Clinical Examination of 2,020 CasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.700714Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.700714/pdfCitation Count: 32
-
OPENTitle: Contribution of rare variant associations to neurodegenerative disease presentationJournal Name: npj Genomic MedicinePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41525-021-00243-3Best OA location URL: https://www.nature.com/articles/s41525-021-00243-3.pdfCitation Count: 20
-
OPENTitle: Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?Journal Name: BMJ Neurology OpenPublisher: BMJVol: 3Issue #: 2Start Page: e000072End Page: e000072Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjno-2020-000072Best OA location URL: https://neurologyopen.bmj.com/content/bmjno/3/2/e000072.full.pdfCitation Count: 1
- Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease2021OPENTitle: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000012633Best OA location URL: https://n.neurology.org/content/neurology/97/14/e1404.full.pdfCitation Count: 24
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 67
-
OPENTitle: The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril endsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25966-wBest OA location URL: https://www.nature.com/articles/s41467-021-25966-w.pdfCitation Count: 67
-
OPENTitle: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00239-xBest OA location URL: https://www.nature.com/articles/s41531-021-00239-x.pdfCitation Count: 43
-
OPENTitle: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomesJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00513-5Best OA location URL: https://www.nature.com/articles/s41746-021-00513-5.pdfCitation Count: 78
-
OPENTitle: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 749468End Page: 749468Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.749468Best OA location URL: https://doi.org/10.3389/fimmu.2021.749468Citation Count: 19
-
OPENTitle: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.723476Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.723476/pdfCitation Count: 7
-
OPENTitle: The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their CarersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1309End Page: 1323Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212611Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212611?id=journal-of-parkinsons-disease%2Fjpd212611Citation Count: 15
-
OPENTitle: Identification of Novel Single-Nucleotide Variants With Potential of Mediating Malfunction of MicroRNA in Congenital Heart DiseaseJournal Name: Frontiers in Cardiovascular MedicinePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcvm.2021.739598Best OA location URL: https://doi.org/10.3389/fcvm.2021.739598Citation Count: 3
-
OPENTitle: Rare variants in the endocytic pathway are associated with Alzheimer’s disease, its related phenotypes, and functional consequencesJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 9Start Page: e1009772End Page: e1009772Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1009772Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1009772&type=printableCitation Count: 6
-
OPENTitle: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 787End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00847-6Best OA location URL: http://hdl.handle.net/1887/3249471Citation Count: 116
-
OPENTitle: Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal ProgressionJournal Name: Frontiers in PsychologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyg.2021.729755Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyg.2021.729755/pdfCitation Count: 9
-
OPENTitle: A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neuronsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.69795Best OA location URL: https://doi.org/10.7554/elife.69795Citation Count: 36
-
OPENTitle: Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear PalsyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.736784Best OA location URL: https://escholarship.org/uc/item/4rt0n68qCitation Count: 4
-
OPENTitle: Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathwayJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 32Issue #:Start Page: 102846End Page: 102846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2021.102846Best OA location URL: https://doi.org/10.1016/j.nicl.2021.102846Citation Count: 43
- Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease2024OPENTitle: Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03642-yBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03642-yCitation Count: 7
-
OPENTitle: O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathologyJournal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 5Start Page: 646End Page: 655Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41589-024-01551-2Best OA location URL: https://www.nature.com/articles/s41589-024-01551-2.pdfCitation Count: 38
-
OPENTitle: Predicting the occurrence of mild cognitive impairment in Parkinson’s disease using structural MRI dataJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2024.1375395Best OA location URL: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1375395/pdfCitation Count: 3